NUKZ - ETF AI Analysis
Top Page
Range Nuclear Renaissance Index ETF (NUKZ)
Rating:52Neutral
Price Target:―
Positive Factors
Strong AUM Base
The fund has a sizable asset base, suggesting solid investor interest and better stability than very small niche ETFs.
Global Nuclear Exposure
Holdings spread across the U.S., Canada, Asia, and Europe give investors access to nuclear-related companies around the world instead of just one country.
Several Strong-Performing Utilities and Industrial Names
Key holdings like GE Vernova, Endesa, Dominion Energy, Rolls-Royce, and others have shown strong or steady year-to-date performance, helping support the fund’s returns.
Negative Factors
Recent Weak Short-Term Performance
The ETF has shown weak performance over the past one and three months, which may signal near-term volatility or pressure on the nuclear theme.
High Expense Ratio
The fund charges relatively high fees, which can eat into long-term returns compared with lower-cost ETFs.
Concentration in Industrials and Utilities
Heavy weighting in industrials and utilities means the fund is sensitive to conditions in these sectors, increasing risk if they face a downturn.
NUKZ vs. SPDR S&P 500 ETF (SPY)
AUM750.11M
RegionGlobal
Expense Ratio0.85%
Beta1.36
IssuerRange
Inception DateJan 24, 2024
Dividend Yield0.91%
Asset ClassEquity
Index TrackedVettaFi Nuclear Renaissance Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume99,626
30 Day Avg. Volume119,922
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
85.20Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering46
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NUKZ Summary
Range Nuclear Renaissance Index ETF (NUKZ) is an exchange-traded fund that follows the VettaFi Nuclear Renaissance Index, focusing on the theme of nuclear energy. It holds companies involved in uranium mining, nuclear power generation, and advanced reactor technology across the U.S. and other countries. Well-known names in the fund include Cameco and Duke Energy. Someone might invest in NUKZ to gain growth exposure to cleaner energy and to diversify beyond traditional oil and gas. A key risk is that it is heavily concentrated in the nuclear sector, so its price can rise or fall sharply with changes in energy policy and sentiment toward nuclear power.
How much will it cost me?The Range Nuclear Renaissance Index ETF (NUKZ) has an expense ratio of 0.85%, meaning you’ll pay $8.50 per year for every $1,000 invested. This is higher than average because it is actively managed, focusing on a specialized sector like nuclear energy, which requires more research and expertise to select investments.
What would affect this ETF?The Range Nuclear Renaissance Index ETF (NUKZ) could benefit from growing global demand for clean energy and advancements in nuclear technology, as governments and industries prioritize decarbonization. However, it may face challenges from regulatory hurdles, public concerns about nuclear safety, and competition from other renewable energy sources. Its global exposure and focus on sectors like Industrials and Utilities position it well for long-term growth, but economic conditions and geopolitical risks could impact its top holdings and overall performance.
NUKZ Top 10 Holdings
NUKZ is tightly wired to the nuclear revival, with a global mix of industrials, utilities, and energy names doing most of the heavy lifting. GE Vernova and Samsung C&T have been rising and help power the story, while steady utilities like Endesa, Dominion, and Duke Energy keep the fund’s engine humming. On the flip side, heavyweight Cameco has been losing steam lately, and Talen Energy and Vistra are dragging performance. Overall, the ETF is concentrated in nuclear-linked infrastructure rather than broad tech, with exposure spread across North America, Europe, and Asia.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Cameco | 8.11% | $58.55M | C$51.75B | 17.75% | 71 Outperform | |
| Endesa SA | 3.85% | $27.80M | €42.78B | 63.19% | 63 Neutral | |
| ― | 3.73% | $26.89M | ― | ― | ― | |
| GE Vernova Inc. | 3.69% | $26.62M | $239.77B | 48.72% | 69 Neutral | |
| Dominion Energy | 3.66% | $26.40M | $62.05B | 19.30% | 63 Neutral | |
| Rolls-Royce Holdings | 3.65% | $26.32M | £115.00B | 40.07% | 71 Outperform | |
| PG&E | 3.19% | $23.05M | $39.00B | 26.82% | 69 Neutral | |
| Duke Energy | 3.19% | $23.03M | $100.63B | 3.81% | 70 Outperform | |
| Talen Energy Corp | 3.18% | $22.93M | $14.35B | -11.93% | 60 Neutral | |
| Emerson Electric Company | 2.98% | $21.53M | $81.62B | 2.15% | 76 Outperform |
NUKZ Technical Analysis
Negative
―
Price Trends
67.47
Negative
68.80
Negative
68.59
Negative
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For NUKZ, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 64.17, equal to the 50-day MA of 67.47, and equal to the 200-day MA of 68.59, indicating a bearish trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NUKZ.
NUKZ Peer Comparison
Comparison Results
Performance Comparison
NUKZ
Range Nuclear Renaissance Index ETF
63.68
5.66
9.76%
IHAK
iShares Cybersecurity & Tech ETF
―
―
―
IVES
Dan IVES Wedbush AI Revolution ETF
―
―
―
GII
SPDR S&P Global Infrastructure ETF
―
―
―
TRFK
Pacer Data and Digital Revolution ETF
―
―
―
ROBT
First Trust Nasdaq Artificial Intelligence & Robotics ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents